Identification of COL4A2 as a Biomarker of Extracellular Matrix Remodeling and Vascular Scaffold in Choroid for Myopia

分享:

简介:

  • 作者: Baizhou Chen; Yangming Xu; Songlin Xie; Xiang Zhou; Lin Wang; Chendong Yuan; Yao Ni; Zhaotian Zhang
  • 杂志: Anatomy and Pathology/Oncology
  • Doi: https://www.doi.org/10.1167/iovs.67.3.31
  • 出版日期: 2026/3/1

论文中使用的产品/服务

询价

摘要

Purpose: To investigate the extracellular matrix (ECM) change in choroid and explore the key regulator of choroidal vascular scaffold in axial myopia.

Methods: Myopia was induced in pigmented rabbits and guinea pigs using the form-deprivation approach. Quantitative label-free proteomics were performed using the samples of rabbits to investigate the differentially expressed proteins (DEPs) in myopic choroid. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment was conducted to explore the potential biomarkers and signal pathways that form the scaffold and regulate the choroid morphology in myopia. Immunoblotting and immunofluorescence were applied to determine the expression and distribution of DEPs in choroid. Adeno-associated virus was used to knock down the expression of COL4A2 to verify its biological function in refraction development and choroid morphology.

Results: Long-term form deprivation significantly induced myopia shifts and decreased the choroidal thickness in pigmented rabbits. Proteomic analysis revealed that COL4A2 negatively regulates vasculature development. Masson’s trichome staining and immunofluorescence showed decreased choroidal thickness and lumen scaffold deformation with decreased collagen IV in form-deprivation myopia (FDM) choroid. Immunoblotting revealed that COL4A2 rather than COL4A1 contributes to the downregulation of collagen IV in FDM choroid. Dysfunction of COL4A2 hindered choroidal vascular scaffold formation, decreased guinea pig choroidal thickness, and promoted myopia shifts with refraction change and axial elongation.

Conclusions: Type IV collagen is a key ECM in construction of the choroidal vascular lumen. COL4A2 is downregulated in FDM choroid, and suppression of COL4A2 impairs the choroid vascular scaffold and promotes myopia shift with decreased choroidal thickness.

关于派真

作为一家专注于AAV 技术十余年,深耕基因治疗领域的CRO&CDMO,派真生物可提供从载体设计、构建到 AAV、慢病毒和 mRNA 服务的一站式解决方案。凭借深厚的技术实力、卓越的运营管理和高标准的服务交付,我们为全球客户提供一站式CMC解决方案,包括从早期概念验证、成药性评估到IITINDBLA的各个阶段。

 

凭借我们独立知识产权的π-alphaTM 293 细胞AAV高产技术平台,我们能将AAV产量提高多至10倍,每批次产量可达1×10¹⁷vg,以满足多样化的商业化和临床项目需求。此外,我们定制化的mRNA和脂质纳米颗粒(LNP)产品及服务覆盖药物和疫苗开发的各个阶段,从研发到符合GMP的生产,提供端到端的一站式解决方案。

下载

用户登录

还没账号? 请注册
手机验证码登录
账号密码登录
手机号码*
验证码*
忘记密码?

首次使用手机号登录将自动为您注册

登录即代表阅读并接受《注册协议》 《用户协议》

新用户注册

已有账号?
手机注册
邮箱注册
手机号码*
验证码*
机构名称*
客户类型*

重置密码

手机找回密码
邮箱找回密码
手机号码*
验证码*
设置新密码*
确认新密码*